"Bile Duct Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the BILE DUCTS.
| Descriptor ID |
D001650
|
| MeSH Number(s) |
C04.588.274.120.250 C06.130.120.120 C06.130.320.120 C06.301.120.250
|
| Concept/Terms |
Bile Duct Neoplasms- Bile Duct Neoplasms
- Bile Duct Neoplasm
- Neoplasm, Bile Duct
- Neoplasms, Bile Duct
Bile Duct Cancer- Bile Duct Cancer
- Bile Duct Cancers
- Cancer, Bile Duct
- Cancers, Bile Duct
- Cancer of the Bile Duct
- Cancer of Bile Duct
|
Below are MeSH descriptors whose meaning is more general than "Bile Duct Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Bile Duct Neoplasms".
This graph shows the total number of publications written about "Bile Duct Neoplasms" by people in this website by year, and whether "Bile Duct Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 5 | 1 | 6 |
| 2017 | 40 | 4 | 44 |
| 2018 | 47 | 3 | 50 |
| 2019 | 18 | 2 | 20 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Bile Duct Neoplasms" by people in Profiles.
-
Changing surgical practice in management of intrahepatic cholangiocarcinoma during the pandemic. Is bridging with systemic therapy safe for our patients? Br J Surg. 2021 04 05; 108(3):e145.
-
Effect of COVID-19 outbreak on community screening program for cancer prevention: A note from endemic area of cholangiocarcinoma. J Cancer Res Ther. 2021 Apr-Jun; 17(2):576.
-
Unchanged surgical management of patients with Cholangiocarcinoma during the COVID-19 pandemic. Dig Liver Dis. 2020 09; 52(9):944-945.
-
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective. Lancet Gastroenterol Hepatol. 2020 08; 5(8):765-775.
-
Intrahepatic Cholangiocarcinoma. Surg Oncol Clin N Am. 2019 10; 28(4):587-599.
-
Reply to: "Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma". J Hepatol. 2019 12; 71(6):1262-1263.
-
Brush Cytology Performance for the Assessment of Biliopancreatic Strictures. Acta Cytol. 2020; 64(4):344-351.
-
Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study. Anticancer Res. 2019 Jun; 39(6):3095-3100.
-
The role of sarcopenia in patients with intrahepatic cholangiocarcinoma: Prognostic marker or hyped parameter? Liver Int. 2019 07; 39(7):1307-1314.
-
Alterations in DNA Damage Repair Genes in Primary Liver Cancer. Clin Cancer Res. 2019 08 01; 25(15):4701-4711.